RT Journal Article
T1 The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study.
A1 Echarri, Ana
A1 Vera, Isabel
A1 Ollero, Virginia
A1 Arajol, Claudia
A1 Riestra, Sabino
A1 Robledo, Pilar
A1 Calvo, Marta
A1 Gallego, Franscisco
A1 Ceballos, Daniel
A1 Castro, Beatriz
A1 Aguas, Mariam
A1 García-López, Santiago
A1 Marín-Jiménez, Ignacio
A1 Chaparro, María
A1 Mesonero, Paco
A1 Guerra, Iván
A1 Guardiola, Jordi
A1 Nos, Pilar
A1 Muñiz, Javier
K1 behavioral health
K1 e-health
K1 home health monitoring
K1 telehealth
K1 telemedicine
AB Objectives: Mobile apps are useful tools in e-health and self-management strategies in disease monitoring. We evaluated the Harvey-Bradshaw index (HBI) mobile app self-administered by the patient to see if its results agreed with HBI in-clinic assessed by a physician. Methods: Patients were enrolled in a 4-month prospective study with clinical assessments at months 1 and 4. Patients completed mobile app HBI and within 48 h, HBI was performed by a physician (gold standard). HBI scores characterized Crohn's disease (CD) as remission
YR 2019
FD 2019-03-08
LK http://hdl.handle.net/10668/13678
UL http://hdl.handle.net/10668/13678
LA en
DS RISalud
RD Apr 6, 2025